Add time:08/12/2019         Source:sciencedirect.com

Cyclo(-Phe(p-NH[1-14C]Ac)-Trp-Lys-(CO(p-N3)C6H4)-Trp-Phe-dPro), in the following named azidobenzamido-008, was synthesized in order to identify binding sites for c(Phe-Thr-Lys-Trp-Phe-dPro), named 008, (a cyclosomatostatin with retro sequence) in liver cell plasma membranes. In the dark the above photolabel was taken up into isolated hepatocytes, inhibiting the sodium dependent uptake of cholate and taurocholate in a competitive manner (Ki for cholate uptake ihibition= 1 μM; Ki for taurocholate uptake inhibition= 5 μM). When activated by flashed light the inhibition became irreversible (IC50 for cholate uptake inhibition = 2 μM; IC50 for taurocholate uptake inhibition = 9 μM) and the activated cyclopeptide bound chiefly to hepatocellular membrane proteins of 67, 54, 50, 37 kDa. Excess of the initial 008, or of cholate or phalloidin partially protected the above membrane components against labeling with14C-labeled azidobenzamido-008. In contrast AS 30 D ascites hepatoma cells, known to be deficient in bile acid and cyclosomatostatin transport, could not be specifically labeled by azidobenzamido-008. The membrane proteins preferentially labeled in hepatocytes (50 and 54 kDa) are integral glycoproteins. The 67 kDa protein is a hydrophilic nonglycosylated membrane component. Independent of labeling with14C-labeled azidobenzamido-008 or with14C-labeled azidobenzamido-taurocholate, the main radioactive peaks in the pH region of 7, 5.5, 5.25 were identical after solubilization with Nonidet P-40 and subsequent isoelectric focusing. Proteins of 67, 54, 50 and 37 kDa could be enriched by use of 008-containing gels in affinity electrophoresis. Binding sites for 008 were not destroyed by SDS or Nonidet P-40 treatment of plasma membranes.

We also recommend Trading Suppliers and Manufacturers of azidobenzamido 008 (cas 113400-63-8). Pls Click Website Link as below: cas 113400-63-8 suppliers